CLS-LOGO-New2021.jpg
CORRECTION: CLS Americas and Unio Health Partners Announce Clinical Study “Micro Ultra-Sound Guided Focal Laser Ablation of Low to Intermediate Risk Prostate Cancer”
25 avr. 2023 11h22 HE | Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif. and SAN DIEGO, April 25, 2023 (GLOBE NEWSWIRE) -- A correction has been issued for a release issued under the same headline earlier today by Clinical Laserthermia Systems Americas,...
CLS-LOGO-New2021.jpg
CLS Americas and Unio Health Partners Announce Clinical Study “Micro Ultra-Sound Guided Focal Laser Ablation of Low to Intermediate Risk Prostate Cancer”
25 avr. 2023 07h00 HE | Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif. and SAN DIEGO, April 25, 2023 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS), a leading provider of office-based, focal laser ablation (FLA) systems for...
CLS-LOGO-New2021.jpg
CLS Americas Announces Agreement with AVANT Concierge Urology to Treat Prostate Cancer Patients with TRANBERG™ Thermal Therapy System
19 avr. 2023 02h50 HE | Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif. and ORLANDO, Fla., April 19, 2023 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS), a leading provider of office-based, focal laser ablation (FLA) systems for...
Polaris Logo - v2.png
By 2032, Global Prostate Cancer Treatment Market Size Will Surpass USD 23.86 Billion, at 7.8% CAGR: Polaris Market Research
02 mars 2023 09h00 HE | Polaris Market Research & Consulting LLP
New York, NY, March 02, 2023 (GLOBE NEWSWIRE) -- Polaris Market Research has published a new research report titled “Prostate Cancer Treatment Market Share, Size, Trends, Industry Analysis Report,...
CLS-LOGO-New2021.jpg
CLS Americas and HALO Precision Diagnostics Announce 25 Patient Post-Market Study to Evaluate CLS’s TRANBERG Thermal Therapy System
08 févr. 2023 12h25 HE | Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif. and INDIAN WELLS, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS), a leading provider of office-based, focal laser ablation (FLA) systems...
ARC logo.png
Prostate Cancer Treatment Market Size to Reach USD 12,152 Million by 2030 Says Acumen Research and Consulting
23 janv. 2023 11h00 HE | Acumen Research and Consulting
LOS ANGELES, Jan. 23, 2023 (GLOBE NEWSWIRE) -- The Global Prostate Cancer Treatment Market Size accounted for USD 8,124 Million in 2021 and is estimated to achieve a market size of USD 12,152...
CLS Americas Exhibits TRANBERG Fusion-Guided Focal Laser Ablation Solution at Western Section AUA Meeting
01 nov. 2022 07h00 HE | Clinical Laserthermia Systems Americas, Inc.
KAUAI, Hawaii, Nov. 01, 2022 (GLOBE NEWSWIRE) -- CLS Americas, a subsidiary of Clinical Laserthermia Systems AB, today announced it will exhibit its TRANBERG™ Thermal Therapy System at the 98th...
Logo.png
Metastatic Castration-Resistant Prostate Cancer Clinical Trial Pipeline Insights | DelveInsight
11 juil. 2022 12h00 HE | DelveInsight Business Research LLP
New York, USA, July 11, 2022 (GLOBE NEWSWIRE) -- Metastatic Castration-Resistant Prostate Cancer Clinical Trial Pipeline Insights | DelveInsight Metastatic castration-resistant prostate cancer...
MetasTx-Logo_HoRes.jpg
MetasTx LLC Raises Funds, Engages Manufacturing Partner, And Advances Phase One Development
07 juin 2022 07h22 HE | MetasTx LLC
BASKING RIDGE, N.J., June 07, 2022 (GLOBE NEWSWIRE) -- MetasTx LLC is driven to create novel therapeutics to treat and prevent metastasis of cancers. Harvey Homan, CEO and Co-Founder has...
CLS-LOGO-New2021.jpg
CLS Americas Debuts Office-Based, Fusion-Guided TRANBERG Focal Laser Ablation System at AUA 2022 Conference
12 mai 2022 07h00 HE | Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- CLS Americas, a subsidiary of Clinical Laserthermia Systems AB, today announced it will debut its Office-Based, MR/US Fusion-Guided, TRANBERG®...